Home > Insider Trading > Filing (0000899243-17-015234)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1269021	Portola Pharmaceuticals Inc	PTLA	()	0331

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1021944	Ltd (Private) Holdings Temasek	60B Orchard Road #06-18, Tower 2 The Atrium@Orchard Singapore U0 238891	No	No	Yes	No
1379348	Ltd Pte Management Fullerton	60B Orchard Road #06-18, Tower 2 The Atrium@Orchard Singapore U0 238891	No	No	Yes	No
1434871	Ltd Pte (Mauritius) Investments Cairnhill	C/O Cim Corporate Services Ltd., Les Cascades, Edith Cavell St. Port Louis O4	No	No	Yes	No
1512375	Ltd Pte (Mauritius) Maxwell	C/O Cim Corporate Services Ltd., Les Cascades, Edith Cavell St. Port Louis O4	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-01	1,700,000	$34.40	4,133,568	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Maxwell (Mauritius) Pte Ltd ("Maxwell") owns 4,133,568 shares of the Issuer's common stock ("Shares") and V-Sciences Investments Pte Ltd ("V-Sciences") owns 750,000 Shares. Maxwell is wholly owned by Cairnhill Investments (Mauritius) Pte Ltd, which is wholly owned by Fullerton Management Pte Ltd ("FMPL"). V-Sciences is wholly owned by Temasek Life Sciences Private Limited, which is wholly owned by FMPL. FMPL is wholly owned by Temasek Holdings (Private) Limited. Accordingly, each of FMPL and Temasek Holdings (Private) Limited, through the ownership described herein, may be deemed to beneficially own the 4,883,568 Shares owned by Maxwell and V-Sciences, collectively.